Related Experiment Video
Updated: Jan 25, 2026

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast
Ylenia Perone1, Aaron J Farrugia2, Alba Rodríguez-Meira1,3
1Department of Surgery and Cancer, Imperial College London, London, UK.
Abstract:
Approximately 30% of ERα breast cancer patients relapse with metastatic disease following adjuvant endocrine therapies. The connection between acquisition of drug resistance and invasive potential is poorly understood. In this study, we demonstrate that the type II keratin topological associating domain undergoes epigenetic reprogramming in aromatase inhibitors (AI)-resistant cells, leading to Keratin-80 (KRT80) upregulation. KRT80 expression is driven by de novo enhancer activation by sterol regulatory element-binding protein 1 (SREBP1). KRT80 upregulation directly promotes cytoskeletal rearrangements at the leading edge, increased focal adhesion and cellular stiffening, collectively promoting cancer cell invasion. Shearwave elasticity imaging performed on prospectively recruited patients confirms KRT80 levels correlate with stiffer tumors. Immunohistochemistry showed increased KRT80-positive cells at relapse and, using several clinical endpoints, KRT80 expression associates with poor survival. Collectively, our data uncover an unpredicted and potentially targetable direct link between epigenetic and cytoskeletal reprogramming promoting cell invasion in response to chronic AI treatment.
Insights
Drug resistance in ERα breast cancer promotes metastasis. We found Keratin-80 (KRT80) upregulation drives cancer cell invasion and stiffens tumors, linking epigenetic changes to poor survival.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Estrogen receptor-alpha (ERα) breast cancer recurrence affects 30% of patients after endocrine therapy.
- The link between endocrine therapy resistance and cancer cell invasiveness remains unclear.
Purpose of the Study:
- To investigate the molecular mechanisms linking drug resistance to increased invasiveness in ERα breast cancer.
- To identify potential therapeutic targets for preventing metastasis in resistant breast cancer.
Main Methods:
- Epigenetic analysis of aromatase inhibitor (AI)-resistant ERα breast cancer cells.
- Investigated Keratin-80 (KRT80) expression and its regulation by sterol regulatory element-binding protein 1 (SREBP1).
- Assessed KRT80's role in cytoskeletal dynamics, cell invasion, and tumor stiffness using cell models and patient samples.
Main Results:
- AI-resistant cells exhibit epigenetic reprogramming of the type II keratin TAD, leading to KRT80 upregulation.
- SREBP1 activates a de novo enhancer, driving KRT80 expression.
- KRT80 promotes cytoskeletal rearrangements, focal adhesion, and cellular stiffening, enhancing cancer cell invasion.
- Patient tumor stiffness correlates with KRT80 levels; increased KRT80 at relapse associates with poor survival.
Conclusions:
- KRT80 upregulation is a direct consequence of epigenetic reprogramming in AI-resistant breast cancer.
- KRT80 drives invasion and tumor stiffening, representing a novel link between epigenetic and cytoskeletal changes.
- KRT80 is a potential therapeutic target for overcoming metastasis in endocrine-resistant breast cancer.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
08:08Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
Related Concept Videos
Endocrine Signaling
Treatment Resistant Cancers
What is the Endocrine System?
The Endocrine System
An Overview of the Endocrine System
The endocrine system collaborates...
Structures of the Endocrine System